Tradestie Institutional Equity Comparison Engine
LGND vs OKUR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
LGND Overall Edge
LGND Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ligand Pharmaceuticals Inc. (LGND) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, LGND trades at 24.0x Forward P/E with 14.4% operating margin (-31.8% YoY revenue) versus OKUR at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, LGND sits in CONSOLIDATION (9th %ile IV; Dealer Gamma Walls on Pro) against OKUR sits in SURGE (100th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
LGND
LGND 24.0x vs OKUR N/M Fwd P/E
Growth & Margin Winner
LGND
Op Margin 14.4% vs 0.0% ยท YoY -31.8% vs +0.0%
Momentum & Technical Winner
LGND
1Y +39.2% vs -2.2% ยท 52W Pos 74% vs 20%
Options & Structure Winner
LGND
CONSOLIDATION (9th %ile IV) vs SURGE (100th %ile IV)
LGND
NASDAQ
Ligand Pharmaceuticals Inc.
Pharmaceutical Preparations
$286.85
-0.03% 1D
Market Cap
$5.7B
1M Return
-6.81%
1Y Return
+39.21%
Forward P/E
24.0x
Unified AI Score
46.5 / 100
HOLD
Tech 32.0
Fund 49.0
Flow 67.0
Mom 56.0
OKUR
NASDAQ
OnKure Therapeutics, Inc. Class A Common Stock
Pharmaceutical Preparations
$2.70
-2.17% 1D
Market Cap
$113.7M
1M Return
+4.65%
1Y Return
-2.17%
Forward P/E
N/M
Unified AI Score
36.0 / 100
SELL
Tech 20.0
Fund 46.0
Flow 64.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
LGND +39.21%
OKUR -2.17%
Spread: +41.38 pp (LGND Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
LGND TTM Op. Margin: 14.4%
OKUR TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on LGND vs OKUR. Trailing 12-month operating profitability (LGND 14.4% vs OKUR 0.0%) and valuation multiples (LGND 24.0x vs OKUR N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | LGND | OKUR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $5.7B | $113.7M | Larger Scale | LGND |
| Trailing P/E Ratio Valuation | 115.2x | N/M | Lower Multiple | LGND |
| Forward P/E Ratio Valuation | 24.0x | N/M | Lower Multiple | LGND |
| Revenue Growth (YoY) Growth | -31.8% | +0.0% | Higher Growth | OKUR |
| Operating Margin (TTM) Profitability | 14.4% | 0.0% | Higher Margin | LGND |
| Net Profit Margin Profitability | 20.3% | 0.0% | Higher Margin | LGND |
| Return on Equity (ROE) Capital Efficiency | 5.4% | -55.2% | Higher ROE | LGND |
| 52-Week Range Position Momentum | 74% ($176โ$327) | 20% ($2โ$5) | Stronger Trend | LGND |
| Beta / 30D Volatility Risk Regime | 0.93ฮฒ ยท 38% Vol | 0.96ฮฒ ยท 100% Vol | Lower Realized Risk | LGND |
| Unified Institutional Score Composite Signal | 46.5 / 100 (HOLD) | 36.0 / 100 (SELL) | Higher Composite | LGND |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full LGND vs OKUR Buy Guide
LGND
CONSOLIDATION
102d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
9th %ile
IV Regime
Compressed (<25th %ile)
OKUR
SURGE
8d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither LGND nor OKUR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.